Search Our Website:

Barbara Binzak Blumenfeld, shareholder in the firm's FDA & Biotechnology section, is quoted in the Bloomberg Law article, "FDA’s Booster OK Puts Pfizer on Data Hunt, Muddles Off-Label Use"